Haematologic Technologies, LLC
Biotechnology company · Essex Junction, Vermont, United States
Haematologic Technologies, LLC is a biotechnology company headquartered in Essex Junction, Vermont, United States. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has received 13 US government small-business research awards (SBIR/STTR) from health agencies, $2.6 million in total, most recently in 2018.
Haematologic Technologies at a glance
What does Haematologic Technologies do?
Operations at its FDA-registered drug sites
US government research funding
13 SBIR/STTR small-business research awards from US health agencies, $2.6 million in total (1989 to 2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Where is Haematologic Technologies located?
Headquarters: Essex Junction, Vermont, United States
- Essex Junction, VermontHaematologic Technologies, LLC dba Prolytix · FDA drug site
Frequently asked questions about Haematologic Technologies
Where is Haematologic Technologies headquartered?
Haematologic Technologies, LLC is headquartered in Essex Junction, Vermont, United States.
What does Haematologic Technologies do?
Haematologic Technologies, LLC is a biotechnology company. Its FDA-registered drug sites are registered for analysis.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences